Evaluating the effects of testosterone and DHA on memory
Parsemus Foundation is helping fund a randomized controlled prospective trial on the impact of testosterone or DHA (fish oil) versus placebo on the onset of amyloid plaque associated with Alzheimer’s disease in men with subjective memory complaint (SMC). The study, at the McCusker Alzheimer’s Research Foundation in Western Australia, will do several types of brain scans to provide objective data on the treatments’ impact. Based on the results of a smaller non-placebo trial with brain scans they have already done, the researchers are optimistic that one or both treatments may slow the development of amyloid plaque and cognitive decline.
• Coverage of the study in bimonthly magazine Australian Ageing Agenda.